Search results
Former Baller Matt Barnes Says We Were The ‘Guinea Pigs’ Of COVID Vaccines Amid Reported Side...
MadameNoire· 2 days agoFormer professional basketball player Matt Barnes gives his candid opinion about the FDA-approved ...
Sanofi reaches agreement with Novavax regarding COVID-19 vaccine
WFMZ Eastern Pennsylvania and Western New Jersey· 5 days agoThe agreement involves co-commercializing the COVID-19 vaccine, developing novel COVID-19-Influenza...
Virginia Tech study shows effects of social media rhetoric during COVID-19 pandemic
WRIC 8 News Richmond· 2 hours agoA Virginia Tech study reveals the effects that social media rhetoric had on COVID-19 infection and...
Trump election lies, COVID misinformation: New far-right Idaho candidates are on the ballot
Idaho Statesman via Yahoo News· 6 hours agoFar-right lawmakers have endorsed fringe views and proposed passing a range of bills, like ones to...
The Silence Around Covid Vaccine Injuries
The Intercept· 2 days agoThis week on Deconstructed, Wightman shares his story with Ryan Grim. Days after receiving an AstraZeneca Covid-19 vaccine in 2021, Wightman ...
AstraZeneca pulls COVID-19 vaccine from global markets
United Press International via Yahoo News· 7 days agoBritish-Swedish drug maker AstaZeneca is pulling its Vaxzevria COVID-19 vaccine from sale globally....
Novavax Stock Just Tripled. Is It Too Late to Buy?
Motley Fool via Yahoo Finance· 7 hours agoLet's find out. Image source: Getty Images. Novavax falls behind First, a quick summary of Novavax's story so far. The vaccine maker's shares soared...
Oregon health officials monitor impact of latest COVID-19 variant "FLiRT"
KGW NewsChannel 8 Portland· 12 hours agoOregon health officials are monitoring the impact of a new COVID-19 variant they believe to be less...
France’s Sanofi in COVID-19 vaccine deal with Novavax
WHTC 1450 Holland· 5 days agoPARIS (Reuters) - Sanofi on Friday announced it has reached a licensing agreement with Novavax to...
Earnings call: GeoVax reports progress on key vaccine trials
Investing.com· 11 hours agoCEO David Dodd discussed significant advancements in the company's Phase 2 clinical trials,...